Terms: = Thyroid cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
57 results:
1. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and validation of a multivariate logistic model for risk factors of thyroid nodules using lasso regression screening.
Liu J; Feng Z; Gao R; Liu P; Meng F; Fan L; Liu L; Du Y
Front Endocrinol (Lausanne); 2024; 15():1346284. PubMed ID: 38628585
[TBL] [Abstract] [Full Text] [Related]
3. The application of autofluorescence system contributes to the preservation of parathyroid function during thyroid surgery.
Shi X; Lv G; Qin J; Li Y; Zheng L; Ding H; Sang J
Langenbecks Arch Surg; 2024 Mar; 409(1):96. PubMed ID: 38483607
[TBL] [Abstract] [Full Text] [Related]
4. Association of ABCG2 Polymorphisms on Triple Negative Breast cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
5. Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia.
Ho J; Kim E; Lee M; Jung I; Jo YS; Lee J
Sci Rep; 2023 Jan; 13(1):1076. PubMed ID: 36658156
[TBL] [Abstract] [Full Text] [Related]
6. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
[TBL] [Abstract] [Full Text] [Related]
7. Dexamethasone for Postoperative Nausea and Vomiting in Papillary thyroid Carcinoma Patients: A Randomized Clinical Trial.
Chen W; Li G; Jiang K; Song J; Du R; Yang H; Gou J; Li Z; Zhu J; Lei J
J Am Coll Surg; 2022 Sep; 235(3):454-467. PubMed ID: 35972165
[TBL] [Abstract] [Full Text] [Related]
8. A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
Luo QW; Gao S; Lv X; Li SJ; Wang BF; Han QQ; Wang YP; Guan QL; Gong T
BMC Cancer; 2022 Jun; 22(1):606. PubMed ID: 35655253
[TBL] [Abstract] [Full Text] [Related]
9. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract] [Full Text] [Related]
10. First-line Gemcitabine
Yamamoto S; Narui K; Ishikawa T; Adachi S; Shimada K; Shimizu D; Yamada A; Sugae S; Tanabe M; Oba M; Morita S; Doi T; Hasegawa S; Morita T; Kito A; Chishima T; Ichikawa Y; Endo I;
Anticancer Res; 2021 Mar; 41(3):1671-1676. PubMed ID: 33788764
[TBL] [Abstract] [Full Text] [Related]
11. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line.
Ghorbani-Anarkooli M; Dabirian S; Zendedel A; Moladoust H; Bahadori MH
Acta Histochem; 2021 Apr; 123(3):151700. PubMed ID: 33667778
[TBL] [Abstract] [Full Text] [Related]
12. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.
Liu X; Huang Z; He X; Zheng X; Jia Q; Tan J; Fan Y; Lou C; Meng Z
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015713
[TBL] [Abstract] [Full Text] [Related]
13. Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.
Chang L; Zhang L; Jia H; Nie Z; Zhang L
Medicine (Baltimore); 2020 Aug; 99(34):e21733. PubMed ID: 32846794
[TBL] [Abstract] [Full Text] [Related]
14. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical value of intact parathyroid hormone levels on the first day after total thyroidectomy on prediction for permanent hypoparathyroidism].
Zheng JW; Cai SY; Song HM; Wang YL; Han XF; Wu HL; Han G; Gao ZG
Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):626-630. PubMed ID: 32727195
[No Abstract] [Full Text] [Related]
16. Measurement of serum intact parathyroid hormone concentration 1 day after total thyroidectomy to assess risk of permanent hypoparathyroidism.
Zheng J; Cai S; Song H; Wang Y; Han X; Han G; Wu H; Gao Z
J Int Med Res; 2020 Jun; 48(6):300060520927199. PubMed ID: 32527180
[TBL] [Abstract] [Full Text] [Related]
17. The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.
van Gerwen M; Sinclair C; Rahman M; Genden E; Taioli E
Endocrine; 2020 Nov; 70(2):356-363. PubMed ID: 32307656
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of cancer Incidence and Mortality in Korea, 2020.
Jung KW; Won YJ; Hong S; Kong HJ; Lee ES
Cancer Res Treat; 2020 Apr; 52(2):351-358. PubMed ID: 32178488
[TBL] [Abstract] [Full Text] [Related]
19. Utilities of
Guan H; Toraldo G; Cerda S; Godley FA; Rao SR; McAneny D; Doherty G; Braverman L; Lee SL
Thyroid; 2020 Apr; 30(4):536-547. PubMed ID: 31996097
[No Abstract] [Full Text] [Related]
20. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
[TBL] [Abstract] [Full Text] [Related]
[Next]
